24th Feb 2023 11:31
(Alliance News) - Belluscura PLC on Friday said its X-PLOR portable oxygen concentrator is now marketed in the US via GoodRx Inc.
The medical device developer that focuses on lightweight and portable oxygen enrichment technology said X-PLOR will be the first medical device in its field marketed by US digital healthcare platform GoodRx.
Bellescura said GoodRx offers consumers free access to transparent and lower prices for branded and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information.
Since 2011, GoodRx has helped consumers save over US45 billion and has been "one of the most downloaded medical apps" over the past decade, Bellescura added.
"In our continued goal of broadening product distribution and making supplemental oxygen more accessible to people throughout the US, we are excited to have the X-PLOR marketed through GoodRx, a recognized leader in making healthcare more accessible and affordable in the US," said Belluscura Chief Executive Officer Robert Rauker.
Shares in Bellescura were up 5.7% to 44.90 pence each in London on Friday morning.
By Greg Rosenvinge, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
Belluscura